Metabolomic characterization of ovarian epithelial carcinomas by HRMAS-NMR spectroscopy

Journal of Oncology

Volumn , Issue , 2011, Pages

  Namer, I J ^a,b   Ben Sellem, D ^a,b   Elbayed, K ^c   Neuville, A ^a   Moussallieh, F M ^a,c   Lang Averous, G ^a   Piotto, M ^c,d   Bellocq, J P ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Université de Strasbourg Faculté de Psychologie   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d Bruker Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANTINEOPLASTIC AGENT; ARGININE; ASPARAGINE; ASPARTIC ACID; CREATINE; FATTY ACID; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCEROL; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; INOSITOL; ISOLEUCINE; LACTIC ACID; LEUCINE; METHIONINE; N ACETYLASPARTIC ACID; PHOSPHORYLCHOLINE; PROLINE; SERINE; SUCCINIC ACID; TAURINE; THREONINE; VALINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CARCINOMA; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; FEMALE GENITAL TRACT CANCER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLOMICS; MUCINOUS CARCINOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY CARCINOMA; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; SEROUS CARCINOMA; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

EID: 79959197094     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/174019     Document Type: Article

References (46)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., Thun M. J., Cancer statistics, 2006 CA: A Cancer Journal for Clinicians 2006 56 2 106 130
2. Podo F., Sardanelli F., Iorio E., Canese R., Carpinelli G., Fausto A., Canevari S., Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases noninvasive imaging approaches Current Medical Imaging Reviews 2007 3 2 123 137 (Pubitemid 46773873)
3. Simcock B., Neesham D., Quinn M., Drummond E., Milner A., Hicks R. J., The impact of PET/CT in the management of recurrent ovarian cancer Gynecologic Oncology 2006 103 1 271 276 (Pubitemid 44374699)
4. Russell P., Lowe D., Fox H., Ovarian epithelial tumours with atypical proliferation Advances in Gynaecological Pathology 1992 Edinburgh, UK Churchill Livingstone 299 320
5. Mackinnon W. B., Russell P., May G. L., Mountford C. E., Characterization of human ovarian epithelial tumors (ex vivo) by proton magnetic resonance spectroscopy International Journal of Gynecological Cancer 1995 5 3 211 221
6. Wallace J. C., Raaphorst G. P., Somorjai R. L., Ng C. E., Fung Kee Fung M., Senterman M., Smith I. C. P., Classification of H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis Magnetic Resonance in Medicine 1997 38 4 569 576 (Pubitemid 27419221)
7. Massuger L. F. A. G., Van Vierzen P. B. J., Engelke U., Heerschap A., Wevers R., H-magnetic resonance spectroscopy: a new technique to discriminate benign from malignant ovarian tumors Cancer 1998 82 9 1726 1730 (Pubitemid 28208924)
8. Boss E. A., Moolenaar S. H., Massuger L. F. A. G., High-resolution proton nuclear magnetic resonance spectroscopy of ovarian cyst fluid NMR in Biomedicine 2000 13 5 297 305
9. Kolwijck E., Engelke U. F., Van Der Graaf M., Heerschap A., Blom H. J., Hadfoune M., Buurman W. A., Massuger L. F., Wevers R. A., N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors NMR in Biomedicine 2009 22 10 1093 1099
10. Iorio E., Mezzanzanica D., Alberti P., Spadaro F., Ramoni C., D'Ascenzo S., Millimaggi D., Pavan A., Dolo V., Canevari S., Podo F., Alterations of choline phospholipid metabolism in ovarian tumor progression Cancer Research 2005 65 20 9369 9376 (Pubitemid 41508005)
11. Hascalik S., Celik O., Sarac K., Alkan A., Mizrak B., Clinical significance of N-acetyl-L-aspartate resonance in ovarian mucinous cystadenoma International Journal of Gynecological Cancer 2006 16 1 423 426
12. Booth S. J., Pickles M. D., Turnbull L. W., In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0Tesla An International Journal of Obstetrics and Gynaecology 2009 116 2 300 303
13. Stanwell P., Russell P., Carter J., Pather S., Heintze S., Mountford C., Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three tesla Investigative Radiology 2008 43 10 745 751
14. McLean M. A., Priest A. N., Joubert I., Lomas D. J., Kataoka M. Y., Earl H., Crawford R., Brenton J. D., Griffiths J. R., Sala E., Metabolic characterization of primary and metastatic ovarian cancer by H-MRS in vivo at 3T Magnetic Resonance in Medicine 2009 62 4 855 861
15. International Federation of Gynecology and Obstetrics, Classification and staging of malignant tumours in the female pelvis Acta Obstetricia et Gynecologica Scandinavica 1971 50 1 7
16. Shimizu Y., Kamoi S., Amada S., Hasumi K., Akiyama F., Silverberg S. G., Toward the development of a universal grading system for ovarian epithelial carcinoma I. Prognostic significance of histopathologic features-problems involved in the architectural grading system Gynecologic Oncology 1998 70 1 2 12 (Pubitemid 28368866)
17. Piotto M., Moussallieh F. M., Dillmann B., Imperiale A., Neuville A., Brigand C., Bellocq J. P., Elbayed K., Namer I. J., Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning H magnetic resonance spectroscopy Metabolomics 2009 5 3 292 301
18. Akoka S., Barantin L., Trierweiler M., Concentration measurement by proton NMR using the ERETIC method Analytical Chemistry 1999 71 13 2554 2557 (Pubitemid 29307625)
19. Wider G., Dreier L., Measuring protein concentrations by NMR spectroscopy Journal of the American Chemical Society 2006 128 8 2571 2576 (Pubitemid 43327933)
20. Tenenhaus M., La Regression PLS. Thorie et Pratique 1998 Paris, France Editions Technip
21. Baslow M. H., N-acetylaspartate in the vertebrate brain: metabolism and function Neurochemical Research 2003 28 6 941 953 (Pubitemid 36438413)
22. Burlina A. P., Ferrari V., Facci L., Skaper S. D., Burlina A. B., Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate Journal of Neurochemistry 1997 69 3 1314 1317 (Pubitemid 27364856)
23. Baslow M. H., Yamada S., Identification of N-acetylaspartate in the lens of the vertebrate eye: a new model for the investigation of the function of N-acetylated amino acids in vertebrates Experimental Eye Research 1997 64 2 283 286
24. Schiebler M. L., Miyamoto K. K., White M., Maygarden S. J., Mohler J. L., In vitro high resolution H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma Magnetic Resonance in Medicine 1993 29 3 285 291 (Pubitemid 23114492)
25. Mackinnon W. B., Huschtscha L., Dent K., Hancock R., Paraskeva C., Mountford C. E., Correlation of cellular differentiation in human colorectal carcinoma and adenoma cells lines with metabolite profiles determined by H magnetic resonance spectroscopy International Journal of Cancer 1994 59 2 248 261 (Pubitemid 24343370)
26. Mahon M. M., Williams A. D., Soutter W. P., Cox I. J., McIndoe G. A., Coutts G. A., Dina R., deSouza N. M., H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration NMR in Biomedicine 2004 17 1 1 9 (Pubitemid 38332095)
27. Mountford C. E., Ramadan S., Stanwell P., Malycha P., Proton MRS of the breast in the clinical setting NMR in Biomedicine 2009 22 1 54 64
28. Sitter B., Bathen T., Hagen B., Arentz C., Skjeldestad F. E., Gribbestad I. S., Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy Magnetic Resonance Materials in Physics, Biology and Medicine 2004 16 4 174 181 (Pubitemid 38657623)
29. Gribbestad I. S., Petersen S. B., Fjsne H. E., Kvinnsland S., Krane J., 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue NMR in Biomedicine 1994 7 4 181 194 (Pubitemid 2104805)
30. Gribbestad I. S., Singstad T. E., Nilsen G., Fjsne H. E., Engan T., Haugen O. A., Rinck P. A., In vivo H MRS of normal breast and breast tumors using a dedicated double breast coil Journal of Magnetic Resonance Imaging 1998 8 6 1191 1197 (Pubitemid 28533659)
31. Makhija S., Howden N., Edwards R., Kelley J., Townsend D. W., Meltzer C. C., Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review Gynecologic Oncology 2002 85 1 53 58 (Pubitemid 34304010)
32. Garca-Velloso M. J., Jurado M., Ceamanos C., Aramenda J. M., Garrastachu M. P., Lpez-Garca G., Richter J.., Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma European Journal of Nuclear Medicine and Molecular Imaging 2007 34 9 1396 1405 (Pubitemid 47312579)
33. Thrall M. M., DeLoia J. A., Gallion H., Avril N., Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer Gynecologic Oncology 2007 105 1 17 22 (Pubitemid 46441448)
34. Nanni C., Rubello D., Farsad M., De Iaco P., Sansovini M., Erba P., Rampin L., Mariani G., Fanti S., 18F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients European Journal of Surgical Oncology 2005 31 7 792 797 (Pubitemid 41194659)
35. Takekuma M., Maeda M., Ozawa T., Yasumi K., Torizuka T., Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer International Journal of Clinical Oncology 2005 10 3 177 181 (Pubitemid 40933691)
36. Simcock B., Neesham D., Quinn M., Drummond E., Milner A., Hicks R. J., The impact of PET/CT in the management of recurrent ovarian cancer Gynecologic Oncology 2006 103 1 271 276 (Pubitemid 44374699)
37. Smith I. C. P., Blandford D. E., Diagnosis of cancer in humans by H NMR of tissue biopsies Biochemistry and Cell Biology 1998 76 2-3 472 476 (Pubitemid 29102032)
38. Moreno A., Ars C., Quantitative and qualitative characterization of H NMR spectra of colon tumors, normal mucosa and their perchloric acid extracts: decreased levels of myo-inositol in tumours can be detected in intact biopsies NMR in Biomedicine 1996 9 1 33 45 (Pubitemid 26310157)
39. Imperiale A., Elbayed K., Moussallieh F., Neuville A., Piotto M., Bellocq J.-P., Lutz P., Namer I.-J., Metabolomic pattern of childhood neuroblastoma obtained by 1H-high-resolution magic angle spinning (HRMAS) NMR spectroscopy Pediatric Blood and Cancer 2011 56 1 24 34
40. Pelech S. L., Vance D. E., Signal transductin via phosphatidylcholine cycles Trends in Biochemical Sciences 1989 14 1 28 30 (Pubitemid 19031703)
41. Glunde K., Ackerstaff E., Natarajan K., Artemov D., Bhujwalla Z. M., Real-time changes in H1 and P31 NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin Magnetic Resonance in Medicine 2002 48 5 819 825 (Pubitemid 35340322)
42. Ackerstaff E., Glunde K., Bhujwalla Z. M., Choline phospholipid metabolism: a target in cancer cells? Journal of Cellular Biochemistry 2003 90 3 525 533 (Pubitemid 37243700)
43. Booth S. J., Pickles M. D., Turnbull L. W., In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0Tesla An International Journal of Obstetrics and Gynaecology 2009 116 2 300 303
44. Okada T., Harada M., Matsuzaki K., Nishitani H., Aono T., Evaluation of female intrapelvic tumors by clinical proton MR spectroscopy Journal of Magnetic Resonance Imaging 2001 13 6 912 917 (Pubitemid 32479950)
45. Friedlander M., Drug resistance in ovarian cancer International Journal of Gynecological Cancer 1992 1, supplement 2 9
46. Bathen T. F., Sitter B., Sjbakk T. E., Tessem M.-B., Gribbestad I. S., Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation Cancer Research 2010 70 17 6692 6696